Mersana Therapeutics, Inc.
MRSN
$0.3659
$0.00982.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 45.10% | 59.69% | 62.13% | 51.31% | 36.74% |
| Total Depreciation and Amortization | -6.17% | 7.32% | 23.89% | 49.38% | 55.72% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -18.42% | -20.33% | -25.07% | -29.79% | -21.75% |
| Change in Net Operating Assets | 62.58% | -63.82% | -159.23% | -145.17% | -149.11% |
| Cash from Operations | 54.21% | 51.24% | 49.48% | -51.54% | -145.03% |
| Capital Expenditure | 100.00% | 93.91% | 79.82% | 60.73% | 50.02% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 134.49% | -90.52% | -131.47% | 191.24% | 131.93% |
| Cash from Investing | 141.58% | -90.46% | -133.91% | 186.25% | 130.43% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1,923.66% | -751.15% | 22.99% | 6.90% | -0.38% |
| Issuance of Common Stock | -99.46% | -93.36% | -95.42% | -95.75% | -30.79% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | 100.00% | 100.00% |
| Cash from Financing | -106.17% | -95.68% | -95.55% | -95.96% | -30.85% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 156.89% | -246.27% | -4,980.28% | -955.62% | 55.57% |